<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">33668791</PMID>
      <DateCompleted>
        <Year>2021</Year>
        <Month>04</Month>
        <Day>16</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2021</Year>
        <Month>04</Month>
        <Day>16</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1422-0067</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>22</Volume>
            <Issue>5</Issue>
            <PubDate>
              <Year>2021</Year>
              <Month>Feb</Month>
              <Day>25</Day>
            </PubDate>
          </JournalIssue>
          <Title>International journal of molecular sciences</Title>
          <ISOAbbreviation>Int J Mol Sci</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Effect of Selected Anionic and Cationic Drugs Affecting the Central Nervous System on Electrical Properties of Phosphatidylcholine Liposomes: Experiment and Theory.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">2270</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms22052270</ELocationID>
        <Abstract>
          <AbstractText>Interactions between phospholipid membranes and selected drugs affecting the central nervous system (CNS) were investigated. Small, unilamellar liposomes were used as biomimetic cell membrane models. Microelectrophoretic experiments on two-component liposomes were performed using the electrophoretic light scattering technique (ELS). The effect of both positively (perphenazine, PF) and negatively (barbituric acid, BA) charged drugs on zwitterionic L-α-phosphatidylcholine (PC) membranes were analyzed. Experimental membrane surface charge density (δ) data were determined as a function of pH. Quantitative descriptions of the adsorption equilibria formed due to the binding of solution ions to analyzed two-component membranes are presented. Binding constants of the solution ions with perphenazine and barbituric acid-modified membranes were determined. The results of our research show that both charged drugs change surface charge density values of phosphatidylcholine membranes. It can be concluded that perphenazine and barbituric acid are located near the membrane surface, interacting electrostatically with phosphatidylcholine polar heads.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Kotyńska</LastName>
            <ForeName>Joanna</ForeName>
            <Initials>J</Initials>
            <Identifier Source="ORCID">0000-0003-2532-4856</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Physical Chemistry, Faculty of Chemistry, University of Bialystok, K. Ciolkowskiego 1K, 15-245 Bialystok, Poland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Naumowicz</LastName>
            <ForeName>Monika</ForeName>
            <Initials>M</Initials>
            <Identifier Source="ORCID">0000-0001-5229-1805</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Physical Chemistry, Faculty of Chemistry, University of Bialystok, K. Ciolkowskiego 1K, 15-245 Bialystok, Poland.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2021</Year>
          <Month>02</Month>
          <Day>25</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Int J Mol Sci</MedlineTA>
        <NlmUniqueID>101092791</NlmUniqueID>
        <ISSNLinking>1422-0067</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000838">Anions</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D001463">Barbiturates</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D002412">Cations</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D008081">Liposomes</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D008567">Membranes, Artificial</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D010713">Phosphatidylcholines</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D012996">Solutions</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>FTA7XXY4EZ</RegistryNumber>
          <NameOfSubstance UI="D010546">Perphenazine</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>WQ92Y2793G</RegistryNumber>
          <NameOfSubstance UI="C032232">barbituric acid</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000838" MajorTopicYN="N">Anions</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001463" MajorTopicYN="N">Barbiturates</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002412" MajorTopicYN="N">Cations</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002490" MajorTopicYN="N">Central Nervous System</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
          <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002645" MajorTopicYN="N">Chickens</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004560" MajorTopicYN="Y">Electricity</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007526" MajorTopicYN="N">Isoelectric Point</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008081" MajorTopicYN="N">Liposomes</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008567" MajorTopicYN="N">Membranes, Artificial</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008954" MajorTopicYN="N">Models, Biological</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010546" MajorTopicYN="N">Perphenazine</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010713" MajorTopicYN="N">Phosphatidylcholines</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012542" MajorTopicYN="N">Scattering, Radiation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012996" MajorTopicYN="N">Solutions</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D055672" MajorTopicYN="N">Static Electricity</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">adsorption equilibria</Keyword>
        <Keyword MajorTopicYN="N">barbituric acid</Keyword>
        <Keyword MajorTopicYN="N">charged drugs</Keyword>
        <Keyword MajorTopicYN="N">electrophoretic light scattering</Keyword>
        <Keyword MajorTopicYN="N">liposomes</Keyword>
        <Keyword MajorTopicYN="N">pH</Keyword>
        <Keyword MajorTopicYN="N">perphenazine</Keyword>
        <Keyword MajorTopicYN="N">surface charge</Keyword>
      </KeywordList>
      <CoiStatement>The authors declare no conflict of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>2</Month>
          <Day>1</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2021</Year>
          <Month>2</Month>
          <Day>18</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2021</Year>
          <Month>2</Month>
          <Day>22</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>3</Month>
          <Day>6</Day>
          <Hour>1</Hour>
          <Minute>3</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>3</Month>
          <Day>7</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2021</Year>
          <Month>4</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">33668791</ArticleId>
        <ArticleId IdType="pmc">PMC7956533</ArticleId>
        <ArticleId IdType="doi">10.3390/ijms22052270</ArticleId>
        <ArticleId IdType="pii">ijms22052270</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Pignatello R., Musumeci T., Basile L., Carbone C., Puglisi G. Biomembrane models and drug-biomembrane interaction studies: Involvement in drug design and development. J. Pharm. Bioallied Sci. 2011;1:4–14. doi: 10.4103/0975-7406.76461.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4103/0975-7406.76461</ArticleId>
            <ArticleId IdType="pmc">PMC3053521</ArticleId>
            <ArticleId IdType="pubmed">21430952</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Knobloch J., Suhendro D.K., Zieleniecki J.L., Shapter J.G., Köper I. Membrane–drug interactions studied using model membrane systems. Saudi J. Biol. Sci. 2015;22:714–718. doi: 10.1016/j.sjbs.2015.03.007.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.sjbs.2015.03.007</ArticleId>
            <ArticleId IdType="pmc">PMC4625119</ArticleId>
            <ArticleId IdType="pubmed">26586998</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Akbarzadeh A., Rezaei-Sadabady R., Davaran S., Rezaei-Sadabady R., Davaran S., Joo S.W., Zarghami N., Hanifehpour Y., Samiei M., Kouhi M., et al.  Liposome: Classification, preparation, and applications. Nanoscale Res. Lett. 2013;8:102. doi: 10.1186/1556-276X-8-102.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1556-276X-8-102</ArticleId>
            <ArticleId IdType="pmc">PMC3599573</ArticleId>
            <ArticleId IdType="pubmed">23432972</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sazhina N.N., Plashchina I.G., Semenova M.G., Pal’mina N.P. Variations in the size and ζ-potential of phosphatidylcholine liposomes with incorporated nutriceuticals in the course of their initiated oxidation. Colloid J. 2020;82:69–75. doi: 10.1134/S1061933X20010159.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1134/S1061933X20010159</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Peetla C., Stine A., Labhasetwar V. Biophysical interactions with model lipid membranes: Applications in drug discovery and drug delivery. Mol. Pharm. 2009;6:1264–1276. doi: 10.1021/mp9000662.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1021/mp9000662</ArticleId>
            <ArticleId IdType="pmc">PMC2757518</ArticleId>
            <ArticleId IdType="pubmed">19432455</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zschörnig O., Opitz F., Pittler J. Interaction of proteins with liposomes as detected by microelectrophoresis and fluorescence. Methods Enzymol. 2003;372:48–64. doi: 10.1016/S0076-6879(03)72003-5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0076-6879(03)72003-5</ArticleId>
            <ArticleId IdType="pubmed">14610806</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kotyńska J., Naumowicz M. Theoretical considerations and the microelectrophoresis experiment on the influence of selected chaotropic anions on phosphatidylcholine membrane surface charge density. Molecules. 2020;25:132.  doi: 10.3390/molecules25010132.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/molecules25010132</ArticleId>
            <ArticleId IdType="pmc">PMC6982888</ArticleId>
            <ArticleId IdType="pubmed">31905730</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fišar Z. Interactions between tricyclic antidepressants and phospholipid bilayer membranes. Gen. Physiol. Biophys. 2005;24:161–180.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16118470</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nikam S.S., Awasthi A.K. Evolution of schizophrenia drugs: A focus on dopaminergic systems. Curr. Opin. Investig. Drugs. 2008;9:37–46.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18183530</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Otręba M., Kośmider L. In vitro anticancer activity of fluphenazine, perphenazine and prochlorperazine. A review. J. Appl. Toxicol. 2020;41:82–94. doi: 10.1002/jat.4046.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/jat.4046</ArticleId>
            <ArticleId IdType="pubmed">32852120</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Heli H., Sattarahmady N., Zare S.N. Electrooxidation and determination of perphenazine on a graphene oxide nanosheet modified electrode. RSC Adv. 2015;5:21005–21011. doi: 10.1039/C5RA01405K.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1039/C5RA01405K</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hong S., Lee M.-Y., Shin K.S., Kang S.J. Perphenazine and trifluoperazine induce mitochondria-mediated cell death in SH-SY5Y cells. Anim. Cells Syst. 2012;16:20–26. doi: 10.1080/19768354.2011.611256.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/19768354.2011.611256</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Otręba M., Wrześniok D., Beberok A., Rok J., Buszman E. Fluphenazine and perphenazine impact on melanogenesis and antioxidant enzymes activity in normal human melanocytes. Acta Pol. Pharm. 2016;73:903–911.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29648716</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cheng H.W., Liang Y.H., Kuo Y.L., Chuu C.P., Lin C.Y., Lee M.H., Wu A.T.H., Yeh C.T., Chen E.I.T., Whang-Peng J., et al.  Identification of thioridazine, an antipsychotic drug, as an antiglioblastoma and anticancer stem cell agent using public gene expression data. Cell Death Dis. 2015;6:e1753. doi: 10.1038/cddis.2015.77.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/cddis.2015.77</ArticleId>
            <ArticleId IdType="pmc">PMC4669717</ArticleId>
            <ArticleId IdType="pubmed">25950483</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tzadok S., Beery E., Israeli M., Uziel O., Lahav M., Fenig E., Gil-Ad I., Weizman A., Nordenberg J. In vitro novel combinations of psychotropics and anti-cancer modalities in U87 human glioblastoma cells. Int. J. Oncol. 2010;37:1043–1051. doi: 10.3892/ijo_00000756.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3892/ijo_00000756</ArticleId>
            <ArticleId IdType="pubmed">20811727</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hänsel W., Umlauff S. Barbiturate analysis with heavy metal ions from the beginning to the present. Pharm. Unserer Zeit. 1993;22:207–213. doi: 10.1002/pauz.19930220423.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/pauz.19930220423</ArticleId>
            <ArticleId IdType="pubmed">8234393</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sideratou Z., Tsiourvas D., Paleos C.M., Tsortos A., Pyrpassopoulos S., Nounesis G. Interaction of phosphatidyl choline based liposomes functionalized at the interface with adenine and barbituric acid moieties. Langmuir. 2002;18:829–835. doi: 10.1021/la011223l.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1021/la011223l</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Herbette L.G., Rhodes D.G., Mason R.P. New approaches to drug design and delivery based on drug-membrane interactions. Drug Des. Deliv. 1991;7:75–118.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1910441</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Seydel J.K., Coats E.A., Cordes H.P., Wiese M. Drug membrane interaction and the importance for drug transport, distribution, accumulation, efficacy and resistance. Arch. Pharm. (Weinh.) 1994;327:601–610. doi: 10.1002/ardp.19943271002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ardp.19943271002</ArticleId>
            <ArticleId IdType="pubmed">7826194</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Martinsen T.C., Fossmark R., Waldum H.L. The Phylogeny and biological function of gastric juice—microbiological consequences of removing gastric acid. Int. J. Mol. Sci. 2019;20:6031.  doi: 10.3390/ijms20236031.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/ijms20236031</ArticleId>
            <ArticleId IdType="pmc">PMC6928904</ArticleId>
            <ArticleId IdType="pubmed">31795477</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhou Y., Raphael R.M. Solution pH alters mechanical and electrical properties of phosphatidylcholine membranes: Relation between interfacial electrostatics, intramembrane potential, and bending elasticity. Biophys. J. 2007;92:2451–2462. doi: 10.1529/biophysj.106.096362.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1529/biophysj.106.096362</ArticleId>
            <ArticleId IdType="pmc">PMC1864824</ArticleId>
            <ArticleId IdType="pubmed">17172308</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gerebtzoff G., Li-Blatter X., Fischer H., Frentzel A., Seelig A. Halogenation of drugs enhances membrane binding and permeation. ChemBioChem. 2004;5:676–684. doi: 10.1002/cbic.200400017.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/cbic.200400017</ArticleId>
            <ArticleId IdType="pubmed">15122640</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Deliconstantunos G., Tsakiris S. Differential effect of anionic and cationic drugs on the synaptosome-associated acetylcholinesterase activity of dog brain. Biochem. J. 1985;229:81–86. doi: 10.1042/bj2290081.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1042/bj2290081</ArticleId>
            <ArticleId IdType="pmc">PMC1145152</ArticleId>
            <ArticleId IdType="pubmed">4038267</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fievet P., Szymczyk A., Labbez C., Aoubiza B., Simon C., Foissy A., Pagetti J., Szymczyk A., Labbez C., Aoubiza B., et al.  Determining the zeta potential of porous membranes using electrolyte conductivity inside pores. J. Colloid Interface Sci. 2001;235:383–390. doi: 10.1006/jcis.2000.7331.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1006/jcis.2000.7331</ArticleId>
            <ArticleId IdType="pubmed">11254318</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pabst G., Kučerka N., Nieh M.-P., Katsaras J.  Liposomes, Lipid Bilayers and Model Membranes: From Basic Research to Application. 1st ed. CRC Press; Boca Raton, FL, USA: 2014. pp. 236–238.</Citation>
        </Reference>
        <Reference>
          <Citation>Sathappa M., Alder N.N. Ionization Properties of Phospholipids Determined by Zeta Potential Measurements. Bio Protoc. 2016;6:e2030. doi: 10.21769/BioProtoc.2030.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.21769/BioProtoc.2030</ArticleId>
            <ArticleId IdType="pmc">PMC5138027</ArticleId>
            <ArticleId IdType="pubmed">27928550</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dobrzyńska I., Kotyńska J., Figaszewski Z. Changes in electrical charge of phosphatidylcholine and phosphatidylserine liposomal membranes caused by adsorption of monovalent ions. Chem. Anal. 2007;52:931–944.</Citation>
        </Reference>
        <Reference>
          <Citation>Alves A.C., Ribeiro D., Horta M., Lima J.L.F.C., Nunes C., Reis S. A biophysical approach to daunorubicin interaction with model membranes: Relevance for the drug’s biological activity. J. R. Soc. Interface. 2017;14:20170408. doi: 10.1098/rsif.2017.0408.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1098/rsif.2017.0408</ArticleId>
            <ArticleId IdType="pmc">PMC5582131</ArticleId>
            <ArticleId IdType="pubmed">28855387</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hidalgo A.A., Caetano W., Tabak M., Oliveira O.N. Interaction of two phenothiazine derivatives with phospholipid monolayers. Biophys. Chem. 2004;109:85–104. doi: 10.1016/j.bpc.2003.10.020.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bpc.2003.10.020</ArticleId>
            <ArticleId IdType="pubmed">15059662</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhu R., Dong Y., Cai X., Huang C. Determination of barbiturates in biological specimens by flat membrane-based liquid-phase microextraction and liquid chromatography-mass spectrometry. Molecules. 2019;24:1494.  doi: 10.3390/molecules24081494.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/molecules24081494</ArticleId>
            <ArticleId IdType="pmc">PMC6515296</ArticleId>
            <ArticleId IdType="pubmed">30995793</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
